Skip to main content

ACADIAN ASSET MANAGEMENT LLC

Position in ADAPY — Adaptimmune Therapeutics PLC

CIK 916542 Boston, MA

Position in ADAPY

as of Dec 31, 2025 · filed Feb 10, 2026
Position Value
$446
-$192,623 QoQ
Shares Held
17,167
-98.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2020
12 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ADAPY Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ACADIAN ASSET MANAGEMENT LLC holds $731,256,203 across 167 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in ADAPY

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2025-12-31 $446 17,167
2025-09-30 $193,069 1,485,153
2025-06-30 $471,393 1,964,141
2025-03-31 $436,988 2,218,215
2024-12-31 $275,006 510,216
2023-06-30 $331,159 358,010
2023-03-31 $338,908 310,925
2022-12-31 $767,221 525,494
2022-09-30 $119,935 111,568
2022-06-30 $23,099 13,588
2022-03-31 $91,068 44,208
2020-12-31 $1,624,589 301,408